This brand name is authorized in Nigeria.
The drug CIPROX-T contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
|
|
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
|
2
|
UNII
033KF7V46H - TINIDAZOLE
|
|
Tinidazole is active against both protozoa and obligate anaerobic bacteria. The activity against protozoa involves Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The mode of action of tinidazole against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-0875 | Tablet | CIPROX-T TABLETS TAB 500 mg; 600 mg | CIPROX-T TABLETS B4-0875 CIPROX-T TABLETS CIPROFLOXACIN 500MG TINIDAZOLE 600MG PURIFIED WATER 0.35 METHYL PARABEN 1.000 PROPYL PARABEN 0.5982 MAIZE STARCH 40.17MG PURIFIED TALC 25.00 MAGNESIUM STEARATE 25.00 SODIUM STARCHGLYCOLATE 20.089MG HYDROXY PROPYL METHYLCELLULOSE 18.75 ISOPROPYL ALCOHOL 0.2767 METHYLENE CHLORIDE 0.2767MG PURIFIED TALC 11.00MG TITANIUM DIOXIDE 11.00MG PROPYLENE GLYCOL 0.0065MG Prescription Only Medicine (POM) TETA PHARMACEUTICALS NIG LTD, PLOT A28, MOKOLA EXTENSION, IBADAN LESANTO LABORATORIES, PLOT NO. 9, 10, 11 & 20, SURVEY NO 53, NEAR RAILWAY BRIDGE, THANE PALGHAR 401404 MAHARASHTRA, INDIA, India 2/23/2023 2/22/2028 | 23/02/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01RA11 | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01R Combinations of antibacterials → J01RA Combinations of antibacterials | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-0875 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.